Academic writing
Scholarship
Books, law review articles, and shorter pieces on administrative law, civil procedure, and health law.
Books
- Why We Can’t Have Nice Things: How Legal Reformers Accidentally Broke AmericaW. W. Norton & Company (2026).
- Health Care Law and Ethics10th ed. (2024) (with Mark Hall, Mary Anne Bobinski, David Orentlicher & I. Glenn Cohen).
Articles and book chapters
- Abundance and the Supreme Court2025 Sup. Ct. Rev. 211 (2025).
- The State Capacity Crisis66 B.C. L. Rev. 2301 (2025) (with David Schleicher).
- Delegation at the Founding: A Response to the Critics122 Colum. L. Rev. 2323 (2023) (with Julian D. Mortenson).
- Constitutional Culture, Partisan Politics, and the Failed Campaign to Topple the Affordable Care ActACS Supreme Court Review 2020–2021.
- Delegation at the Founding121 Colum. L. Rev. 277 (2021) (with Julian D. Mortenson). Named best article in the field in 2022 by the ABA Section on Administrative Law and Regulatory Practice.
- What’s Left of the Affordable Care Act? A Progress Report6 Russell Sage Found. J. Soc. Sci. 42 (2020) (with Helen Levy & Andrew Ying).
- The Coronavirus and the Risks to the Elderly in Long-Term Care32 J. of Aging & Soc. Pol’y 310 (2020) (with William Gardner & David States).
- Executive Power and the Affordable Care Actin The Trillion Dollar Revolution (Abbe Gluck & Ezekiel Emanuel eds., 2020).
- The Procedure Fetish118 Mich. L. Rev. 345 (2019).
- The Orphan Drug Act at 35: Observations and Outlook for the 21st Century19 Innovation Policy and the Economy 99 (2019) (with Benjamin Berger, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern).
- The Dubious Empirical and Legal Foundations of Workplace Wellness Programs27 Health Matrix 59 (2017) (with Adrianna McIntyre, Austin Frakt & Aaron Carroll).
- Remedial Restraint in Administrative LawColum. L. Rev. 253 (2017).
- Federalism and the End of Obamacare127 Yale L.J. F. 1 (2017).
- Legal Limits and the Implementation of the Affordable Care Act164 U. Pa. L. Rev. 1715 (2016).
- Medicine as a Public Calling114 Mich. L. Rev. 57 (2015). Winner of the Richard D. Cudahy Writing Competition on Regulatory and Administrative Law.
- Correcting Signals for Innovation in Health CareHamilton Project, Brookings Inst. (Oct. 2015) (with Amitabh Chandra & Austin B. Frakt).
- No Good Options: Picking Up the Pieces After King v. Burwell125 Yale L.J. Forum 13 (2015) (with David K. Jones).
- Three Words and the Future of the Affordable Care Act40 J. Health Pol., Pol’y & L. 589 (2015).
- The Puzzling Presumption of Reviewability127 Harv. L. Rev. 1285 (2014).
- Essential Health Benefits and the Affordable Care Act: Law and Process39 J. Health Pol., Pol’y & L. 441 (2014) (with Helen Levy).
- Bedside Bureaucrats: Why Medicare Reform Hasn’t Worked101 Geo. L.J. 520 (2013).
- Agency Hygiene89 Tex. L. Rev. See Also 1 (2010).
- Centralized Oversight of the Regulatory State106 Colum. L. Rev. 1260 (2006) (with Richard Revesz). Named best article in the field in 2006 by the ABA Section on Administrative Law and Regulatory Practice.
Shorter works
- Most-Favored-Nation Drug Pricing—How Courts Could Shape Future Health Regulation6 JAMA Health Forum e255440 (2025) (with Craig Garthwaite & Benedic Ippolito).
- Preventive Care at the Supreme Court393 New Eng. J. Med. 729 (2025).
- Medicare Coverage of Aducanumab—Implications for State Budgets385 New Eng. J. Med. 2019 (2021) (with Rachel Sachs).
- Ending the Campaign to Undo the ACA in the Courts385 New Eng. J. Med. 673 (2021).
- Is Obamacare Really Unconstitutional?382 New Eng. J. Med. 2019 (2021).
- Importing Prescription Drugs from Canada382 New Eng. J. Med. 1777 (2020) (with Rachel Sachs).
- It’s Time to Reform the Orphan Drug ActNEJM Catalyst (Dec. 19, 2018) (with Amitabh Chandra, Craig Garthwaite & Ariel D. Stern).
- Limiting State Flexibility in Drug Pricing379 New Eng. J. Med. 1002 (2018) (with Rachel Sachs).
- Reform at Risk—Mandating Participation in Alternative Payment Plans378 New Eng. J. Med. 1663 (2018).
- Are Medicaid Work Requirements Legal?319 JAMA 763 (2018).
- Scientific Trials—In the Laboratories, Not the Courts178 JAMA Int. Med. 7 (2018) (with Aaron Carroll & Pieter A. Cohen).
- Small Change, Big Consequences—Partial Medicaid Expansions under the ACA377 New Eng. J. Med. 1004 (2017) (with Adrianna McIntyre & Allan M. Joseph).
- Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule43 J. Health Pol. Pol’y & L. 5 (2018) (with Rachel Sachs & Darius Lakdawalla).
- Trouble on the Exchanges—Does the United States Owe Billions to Health Insurers?375 New Eng. J. Med. 2017 (2016).
- A Legal Setback for the Affordable Care Act374 New Eng. J. Med. 2307 (2016).
- Transparency and the Supreme Court—Can Employers Refuse to Disclose How Much They Pay for Health Care?373 New Eng. J. Med. 34 (2016) (with Christopher Koller).
- Protection or Harm? Suppressing Substance-Use Data372 New Eng. J. Med. 1879 (2015) (with Austin B. Frakt).
- Predicting the Fallout from King v. Burwell372 New Eng. J. Med. 101 (2015) (with David K. Jones & Timothy Stoltzfus Jost).
- The Legality of Delaying Key Elements of the ACA370 New Eng. J. Med. 1967 (2014).
- Why It’s Called the Affordable Care Act110 Mich. L. Rev. First Impressions 1 (2011) (with Jill R. Horwitz).